Lacosamide G.L.

Lacosamide, the active ingredient in Lacosamide G.L., is an anticonvulsant presented as an intravenous solution for intravenous use. It treats partial‑onset seizures as adjunctive therapy in patients with epilepsy.

GNH USA supplies Lacosamide G.L. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacosamide is an antiepileptic medication used in the management of seizure disorders.

Partial‑onset seizures: Reduces the frequency of seizure episodes when added to existing therapy. Adjunctive therapy for epilepsy: Improves overall seizure control in patients with refractory epilepsy. Refractory epilepsy: Enhances seizure control when other treatments are insufficient.

Common Side Effects: - Dizziness - Nausea - Headache - Fatigue

Serious or Rare Side Effects: - Cardiac arrhythmia (e.g., atrioventricular block) - Severe skin reactions such as Stevens‑Johnson syndrome - Respiratory depression

Before initiating therapy, consider the following precautions: - Renal impairment: Adjust monitoring and dosing as needed. - Hepatic impairment: Use with caution and monitor liver function. - Concomitant antiepileptics: Observe for additive central nervous system depression. - Pregnancy: Potential risk unknown; use only if benefit outweighs risk. - Cardiac history: Monitor ECG for conduction abnormalities. Store at 2-8°C: Keep refrigerated, protect from light, do not freeze or shake.

Lacosamide may interact with several drug classes. Review the following interactions: Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., carbamazepine) may reduce lacosamide efficacy. - Co‑administration with other sodium‑channel blockers can increase CNS depression. - Use with QT‑prolonging agents may heighten arrhythmia risk.

Moderate Interactions (Monitor Closely): - Combination with other antiepileptics may require dose adjustments. - Concurrent anticoagulants could increase bleeding tendency. - Alcohol may enhance dizziness and sedation.